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Expression of the MDRl gene, which encodes P-glycoprotein, is increased under some stress conditions. WC have repotted that quercedn. a
bioflavonoid, inhibits the expression of heat-shock proteins. WC have identified the effects of quercetin on the MDRl gene expression n the human 
hepatocarcinoma cells line. HcpG?. The increase of P-glycoprolein synthesis and MDA/ mRNA accumulation caused by exposurL 1~ arscnite were 
inhibited by quercetin. The CAT assay suggested that quercctin suppressed the transcriptional ctivation of the MDRl gene after exposure to 
arseniLe. Although many drugs that prevent he Pglycoprotcin fumion have been reporlcd, this is the first report to describe the inhibition of 
MDR! expression by u leagent. 
Heal :.hock; Stress protein: MDRI: Muhidrug resistance; PXilycoprotcin 
I. INTRODUCTION 2. MATERIALS AND METHODS 
The development of low levels (two- to several-fold) 
of multidrug resistance in cultured cells is initially ac- 
companied by elevated expression of the MDA1 gene 
without gene amplification [I]. The expression of 
MDRl is induced in human renal adcnocarcinoma ceil 
lines (HTB-44 and HTB-46) [2] and a human hepa- 
tocarcinoma cell line (HepG2) [33 after exposure to 
some stresses. Because the emergence of cancer cells 
that have acquired 2- to 3-fold resistance should be a 
serious problem in chemotherapy, reagents that inhibit 
the increase of MDA1 expression might be useful to 
suppress the emergence of resistant cells. 
Quercetin, a bioflavonoid widely distributed in 
plants, has many biological effects [4-61 and inhibits the 
synthesis of heat-shock proteins induced by heat shock 
and other stresses [7]. Quercetin inhibited the induction 
of I1sp70 at the level of rnRNA accumulation through 
the inhibition of the activation of a heat-shock factor 
(HSF). In this report we showed that quercetin inhibited 
the increase of P-glycoprotein synthesis and MDRI 
mRNA in HepG2 cells after exposure to sodium arsen- 
ite. The CAT assay analysis indicated that quercetin 
affected the transcriptional ctivity of MDRI. 
Abbreviarioss: HSE, heat shock responsive lement; HSF. heal shock 
factor; CAT, chloramphenicol acctyltransfcrase. 
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2.1 aDrug ui!ditiotl. rmwbulic fabcling, and itttrrrunoprecipitution 
Cells were trcatcd with 100 PM quercctin for 4 h, and then treated 
wilb 100 MM sodium arscnite for 4 h or heat shock at 4?C for 2 h 
in the prcsencc of 100 pM quercetin. After recovering for 2 h in fresh 
medium containing quercctin. cells were labeled with [‘5S]methioninc 
for I h and harvested by adding lysis bulI’er (1% Nonidct P-40, 150 
mM NaCI, SO mM Tris-HCI. pH 8.0, 5 mM EDTA. 2 mM N-eth- 
ylmuleimide, 2 mM Ip-aminophcnyl)methanesulfonyl fluoride hydra. 
chloride, I pB/rnl leupeptin, and I pgrnl pepstatin). Cell lysates with 
the same amount of radioaclivily were reacted with the anti@- 
ylycoprotcin monoclonal antibody C219 (Centocor) for 1 h at 4’C. 
The P-glycoprotcin-CZ19 complexes were pr cipitated using protein- 
A-Sepharosc. Electrophoresis was done with 7% PAGE as described 
by Liny et al. [S]. 
2,2, S/or h/or hydridimiort. und riborrucleusc protcctiorl 
Slot blot hybridization and ribonuclease protection assay were done 
as described [3]. Comparable RNA loading was confirmed using a 
human psuclin probe [9]. 
Cells were xposed to lOO#M quercetin and IOOyM sodium arsen- 
itc 4 days after the tnnsfection because DNA tmnsfcction and glyc- 
crol shock may cause some stresses. Cell extracts that showed Ihe same 
j%&i!aclosidase activity were used for the CAT assay as described 
previously [3]. 
3. RESULTS 
3.1, Qumetin itthibits the increase of P-glycopro~in 
syttthesis ittduced by arserrirc 
To analyze the effect of quercetin on P-glycoprotein 
synthesis after exposure to arsenite, HepG2 cells were 
treated with arsenite and quurtiiin and CS# extracts 
were immunoprecipitated using the anti-P-glycoprotein 
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Fig. 1. lnhibition of the increase of P-glyoprotein synthesis caused by 
exposure to arsenile. HepG2 cells treated with or without 190 PM 
sodium arsenite or heat shocked (4?C, 2 h) in the presence or absence 
of 100pM qucrcetin were labeled with [%]methionine and analyzed 
as described in Materials and Methods. The positions of size markers 
in kilodaltons arc on the left. 
nlonoclonal antibody, C219. The exposure to arsenite 
caused a U-fold increase in the P-glycoprotein synthc- 
sis (Fig. 1, lane 2) Quercetin slightly inhibited the consti- 
tutive synthesis of P-glycoprotein (lane 3). Quercetin, 
however, completely inhibited the increase of the P- 
(A) 
glycoprotein synthesis caused by exposure to arsenite 
(lane 4). Heat shock at 42°C for 2 h did not increase the 
synthesis of P-glycoprotein in HepG2 significantly (lane 
5) nor did quercetin affect P-glycoprotein synthesis after 
heat shock (lane 6). 
3.2. Querceth irthibits the increase qf’ MDRl rnRNA 
The increase in the P-glycoprotein synthesis after ex- 
posure to arsenite was due to the mRNA accumulation 
of MDRI [3], To examine whether quercetin inhibits the 
increase of MDRZ mRNA after exposure to arsenite, 
slvt blot anaiysis of total RNA and ribonuclease protec- 
tion assay were done (Fig. 2). MDRi mRNA tran- 
scribed from the downstream promoter was increased 
after exposure to arsenite (Fig. 2A and B, lane 2). Den- 
sitometric scanning of ribonuclease protection indicated 
arsenite treatment increased MDA! mRNA 2.6.fo!d. 
Quercetin completely inhibited the increase of MDRZ 
mRNA after exposure to sodium arsenite (lane 4), while 
it did not affect the level of MDRl mRNA before the 
exposure (lane 3). Quercetin reduced the increase of 
11~~70 mRNA induced by sodium arsenite as described 
previously [7] (Fig. 2A). The mRNA level of /3-actin 
gene did not change after exposure to these agents (Fig. 
2A). 
3.3. Qltercetin idibits the trurrscr~tion of MDRl 
Our previous study suggested that transcriptional c- 
(W 
hsp70 
p-actin 
Fig. 2. Inhibition of the increase of MDA1 mRNA accumulation. (A) Slot blot hybridi;tition. HepG? cells treated with or without sodium arscnite 
in the presence or absence of qucrcetin. Twelve micrograms of total RNA and two-fold serial dilutions were applied to GeneScreen plus and 
hybridized with a MDA/ probe. Two micrograms of RNA were hybridized with a hsp70 probe or humanp-actin probeasacontrol. (B) Ribonuclease 
protection analysis. Total RNA (IO pug) was extracted from untreated HepCj? cells (lane I), trcatcd with sodium arsenite (lane 2). qucrcetin (lane 
j), PILI both real;rnla (lane 4), from drug-sensitive Ki%1 cells (lane 5), and from drug-resistant KW5 cells (lane 6). Nufleotide numbers of the 
protected fragments are indicated on the left. The 134.nucleotide fragmcnl is the transcript from the major initiation site of the downstream 
promoter. The 550.nucleotidc fragment in lane 2 in considered to bc the nascent ranscript [splicing inlermediete) from tl?e downstream promoter. 
The 323-nucleotidr f agment in lane 6 is the transcript from the upstreum promoter [1 I]. 
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Fig. 3. CAT assay analysis. Plasmid DNA pMPlCAT or pBLCAT2 
was transfected to HepG2. Cells wcrc treated with or without arscnitc 
in the presence or abscncc of qucrcetin as described in Materials and 
Methods. The CAT activity is shown by the percent ratio relative to 
the CAT activhy of cell extracts of untreated cells. Each value is the 
average (shown under each bar) and standard deviation of live expcr- 
iments. 
tivation is involved in the increase of MDRI mRNA 
caused by sodium arsenite and depends on a GO-bp re- 
gion containing two heat-shock responsive elements 
(HSEs) [3]. To discover whether quercetin inhibits the 
transcriptional ctivation of the MDRI gene after expo- 
sure to arsenite, pMP1 CAT [3], which contains the CAT 
gene under the control of the downstream promoter cf 
MDA], was transfected into HepG2 cells, and the CAT 
assay was done. Four hours after addition of 100 /M 
of quercetin, cells were treated with or without sodium 
arsenite for an additional 4 h in the presence of quer- 
cetin. After 2 h of incubation with fresh medium con- 
taining quercetin, the CAT activity in cell extracts was 
assayed. The CAT activity of pMPlCAT was increased 
2.3-fold after arsenite treatment while the CAT activity 
of pBLCAT2 [IO], which contains the rk promoter, did 
not change (Fig. 3). Quercetin did not affect the pro- 
moter activity of either pMPlCAT or pBLCAT2 in the 
absence of arsenite. In the presence of arsenite, how- 
ever, quercetin suppressed the CAT activity of 
pMPlCAT to the level without arsenite treatment. The 
CAT activity of pBLCAT2 was not changed in the pres- 
ence of these agents. These results suggested that quer- 
cetin specifically inhibited the increase of transciptional 
activity of the MDRI gene induced by arsenite. 
4. DISCUWON 
Transcriptional activation of heat-shock protein 
genes by heat shock or other stresses i regulated by the 
activation of HSF. Activated HSF post-transcription- 
ally acquires DNA binding ability. We have reported 
that quercetin inhibited the induction of heat-shock 
proteins [7]. Treatment with quercetin inhibited the 
binding of HSF to HSEs in cell extracts activated in 
vivo and in vitro by heat shock (Hosokawa, N., unpub- 
lished). Thus quercetin interacts with HSF, and inhibits 
the induction of heat-shock proteins after heat shock 
through the inhibition of HSF activation. 
The MDRI gene has two HSEs on the promoter and 
its expression is increased by heat shock [2] or arsenite 
treatment [3]. Deletion analysis of the MDRf promoter 
indicated that the transcriptional ctivation after expo- 
sure to arsenite depended on a 60.bp region containing 
two HSEs [3]. Quercetin inhibited the increase of P- 
glycoprotein synthesis and MDA1 gene expression after 
exposure to sodium arsenite, probably through the inhi- 
bition of HSF activation. 
Many reagents have been screened for reversing mul- 
tidrug resistance and some calcium channel blockers, 
such as verapamil and quinidine and other chemicals, 
have been reported to have this property. These revers- 
ing agents interact with P-glycoprotein and inhibit its 
function competitively. However, the most promising 
way to conquer multidrug resistance should be to sup 
press the emergence of cancer cells with acquired resis- 
tance. This is the first report to describe a reagent hat 
inhibits the increase of the MDRI gene expression. 
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